ReviewFrontiers in endocrinology2022

Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.

Stefan Kölker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.